Position in ACLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$45,345,977
New position
Shares Held
394,931
first reported quarter
Ownership
0.675%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Magnetar Financial LLC holds $179,874,666 across 37 Biotechnology names. ACLX ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,986,058 | $57,638,397 | |
| 2 | ACLX |
Arcellx, Inc.
This page
|
394,931 | $45,345,977 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
869,229 | $34,969,082 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
281,614 | $14,846,689 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
645,173 | $13,832,508 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
16,009 | $2,705,840 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,811 | $1,994,943 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
67,626 | $1,002,216 |
All Filings in ACLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,345,977 | 394,931 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||